Results 121 to 130 of about 87,303 (273)

Modulation of CCR5 expression and R5 HIV-1 infection in primary macrophages exposed to sera from HESN, LTNP, and chronically HIV-1 infected people with or without natural antibodies to CCR5

Virus Research
CCR5 is the main co-receptor for HIV-1 cell entry and it plays key roles in HIV-1 mucosal transmission. Natural anti-CCR5 antibodies were found in HIV-1-exposed seronegative and long-term non-progressor subjects, suggesting a role in controlling viral ...
Iole Farina, Mauro Andreotti, Claudia Pastori, Roberta Bona, Clementina Maria Galluzzo, Roberta Amici, Cristina Purificato, Caterina Uberti-Foppa, Agostino Riva, Maria Cristina Gauzzi, Lucia Lopalco, Laura Fantuzzi   +11 more
doaj   +1 more source

The frequency of CCR5 promoter polymorphisms and CCR5 32 mutation in Iranian populations [PDF]

Iranian Journal of Basic Medical Sciences, 2015
Evidence showed that chemokines serve as pro-migratory factors for immune cells. CCL3, CCL4 and CCL5, as the main CC  chemokines subfamily members, activate immune cells through binding to CC chemokine receptor 5 or CCR5.
Mohammad Zare-Bidaki, Masoud Karimi-Googheri, Gholamhossein Hassanshahi, Nahid Zainodini, Mohammad Kazemi Arababadi   +4 more
doaj  

Establishment of a novel CCR5 and CXCR4 expressing CD4⁺ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists

Retrovirology, 2004
Background CCR5 and CXCR4 are the two main coreceptors essential for HIV entry. Therefore, these chemokine receptors have become important targets in the search for anti-HIV agents.
De Clercq Erik, Vermeire Kurt, Hatse Sigrid, Princen Katrien, Schols Dominique   +4 more
doaj   +1 more source

CCR5 predicts neurotoxicity in CAR‐T‐cell therapy

British Journal of Haematology, EarlyView.
Patients undergoing chimeric antigen receptor T (CAR T)‐cell therapy are at risk of developing immune effector cell‐associated neurotoxicity syndrome (ICANS). We observed an upregulation of CCR5 and CCR2 expression in CD4+ T cells among patients who developed ICANS.
Ayal Rozenberg, Shahar Shelly, Raz Winer, Riva Fineman, Shani Haller, Shimrit Ringelstein‐Harlev, Israel Henig, Dana Yehudai‐Ofir, Tsila Zuckerman, Tamar Tadmor, Reut Harel, Esther Ganelin‐Cohen, Ofrat Beyar‐Katz   +12 more
wiley   +1 more source

Protein tyrosine phosphatases as emerging targets for cancer immunotherapy

British Journal of Pharmacology, EarlyView.
Abstract Contemporary strategies in cancer immunotherapy, despite remarkable success, remain constrained by inherent limitations such as suboptimal patient responses, the emergence of drug resistance, and the manifestation of pronounced adverse effects. Consequently, the need for alternative strategies for immunotherapy becomes clear.
Zihan Qu, Jiajun Dong, Zhong‐Yin Zhang
wiley   +1 more source

Renal allograft rejection in chemokine receptor Ccr1-/-, Ccr5-/- and Ccr1-/-/Ccr5-/- mice and impact of Ccr5 deficiency on macrophage polarization

, 2009
Previous studies showed that loss of the chemokine receptor Ccr1 or Ccr5 has a beneficial effect on survival of cardiac, carotid, corneal and islet allografts in mice. Additionally, human renal allograft recipients homozygous for a null allele of CCR5 (CCR5delta32) experience significantly prolonged allograft survival.
openaire   +3 more sources

Epitope Mapping of CCR5 Reveals Multiple Conformational States and Distinct but Overlapping Structures Involved in Chemokine and Coreceptor Function [PDF]

, 1999
Benhur Lee, Matthew Sharron, Cédric Blanpain, Benjamin J. Doranz, Jalal Vakili, Pui Setoh, Ellen L. Berg, Gao Liu, H. Robert Guy, Stewart R. Durell, Marc Parmentier, Chung Nan Chang, Ken Price, Monica Tsang, Robert W. Doms   +14 more
openalex   +1 more source

Organoid Models to Study Human Infectious Diseases

Cell Proliferation, EarlyView.
Our manuscript reviews the role of organoids as models for studying human infectious diseases, highlighting their irreplaceable contributions to drug testing and vaccine development for significant infectious diseases including HIV, ZIKV, SARS‐CoV‐2 and MPXV.
Sijing Zhu, Dan Chen, Xinzhi Yang, Liuliu Yang, Yuling Han   +4 more
wiley   +1 more source

The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. [PDF]

, 1998
Suofu Qin, James B. Rottman, Patricia N. Myers, Nasim Kassam, Michael E. Weinblatt, Marcel Loetscher, A E Koch, Bernhard Moser, Charles R. Mackay   +8 more
openalex   +1 more source

CRISPR Technology in Disease Management: An Updated Review of Clinical Translation and Therapeutic Potential

Cell Proliferation, EarlyView.
CRISPR‐Cas systems offer transformative genome editing capabilities for precise manipulation of cellular genes. This enables two main therapeutic avenues: ex vivo modification of patient cells for re‐transplantation or direct in vivo gene targeting via advanced delivery methods.
Bahareh Farasati Far, Marziyeh Akbari, Mohammad Amin Habibi, Morteza Katavand, Sherko Nasseri   +4 more
wiley   +1 more source